In this detailed piece, Scientific American's David H. Freedman examines emerging strategies to extend healthspan. The article outlines how therapies like rapamycin and senolytic drugs, combined with AI-driven insights, delay aging. For instance, advanced screenings reshape preventive care, offering promising real-world applications.